Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

Ad Right Top

Latest News

Mylan, U.S. finalize EpiPen settlement

Mylan NV finalized a $465 million settlement with the U.S. Justice Department, resolving claims it overcharged the government for its EpiPen emergency allergy treatment.

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2017 Focus: Payers, Biotech, HBA WOTY and more!

Subscribe

Ad Right Bottom

Main Navigation